SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-005772
Filing Date
2021-01-27
Accepted
2021-01-27 20:24:10
Documents
2
Period of Report
2021-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4983
2 POA DOCUMENT poa.txt EX-24.3_958122 3011
  Complete submission text file 0001209191-21-005772.txt   9382
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address
Huang Alice Shih-hou (Reporting) CIK: 0001842618 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 21561631